Industries

Legal leadership for Healthcare & Life Sciences.

The companies that discover, make, insure and deliver care operate under overlapping federal regulators — FDA, HHS-OIG, CMS, DOJ, FTC, OCR, the SEC — where one enforcement action can dwarf the team that prevents it. We recruit the regulatory, compliance and IP leaders who make legal mission-critical, and place the firm-side lawyers who advise them.

01 The landscape

In life sciences, the legal team prevents the action that would dwarf its own cost.

Healthcare & Life Sciences is one of the most legally intensive sectors in the economy. The companies that discover, manufacture, insure and deliver care answer to overlapping federal regulators — FDA, HHS-OIG, CMS, DOJ, FTC, OCR and the SEC — and to fraud-and-abuse statutes that make legal and compliance mission-critical rather than back-office. A single False Claims Act resolution, FDA warning letter or consent decree, OCR HIPAA penalty or CMS audit can dwarf the cost of the legal team that prevents it.

That shapes two parallel in-house hiring markets. A typical large pharma, device-maker, health system or payer maintains dedicated FDA/regulatory counsel, fraud-and-abuse and compliance counsel, IP teams, privacy officers, reimbursement specialists and government-investigations counsel — functions far less developed in most other industries. Compliance is frequently structured as an independent function reporting to the board, reflecting OIG expectations and the consequences of corporate integrity agreements. The result is two tracks — legal, led by the GC/CLO, and compliance, led by the CCO/CECO — both staffed at a premium relative to general industry.

The macro thesis is the same across all six sub-sectors — regulation, enforcement and IP create durable, counter-cyclical demand for specialized legal talent — but the specific regulators, statutes and risk profiles differ enough by sub-sector that hiring profiles diverge sharply. That is what the cards below map.

02 The market in numbers

What the data says about life-sciences legal pay and enforcement

Every figure below is sourced. In-house pay sits well above the broader bar, the compliance role is rising fastest of all, and the enforcement exposure these hires exist to manage runs into the billions.

$151,160
Median annual wage for lawyers in the U.S. (all industries). In-house healthcare and life-sciences counsel sit well above this baseline.
U.S. Bureau of Labor Statistics, OOH — Lawyers (May 2024)
$640,958 / $527,080
Average total cash compensation, Chief Legal Officer / General Counsel (global, 2024 target). Life sciences consistently ranks among the highest-paying sectors for these roles.
Major, Lindsey & Africa, 2024 In-House Counsel Compensation Survey
~$693,000
Average U.S. Chief Compliance Officer target earnings (base + bonus) — a 49% increase over 2022, the fastest-rising in-house legal role, concentrated in regulated industries like healthcare and life sciences.
Major, Lindsey & Africa, 2024 In-House Counsel Compensation Survey
$2.9B total / ~$1.7B healthcare
DOJ False Claims Act settlements & judgments, FY2024; roughly $1.7B involved the health care industry, with 979 qui tam suits filed — a record high.
U.S. Department of Justice, FCA recoveries (FY2024, via K&L Gates)
$1.625M
Total compensation for a healthcare general counsel at a public company over $10B revenue. Private peers earn roughly half in every revenue band.
BarkerGilmore Healthcare & Life Sciences Compensation Survey (2023, via Legal Dive)

Sources: U.S. Bureau of Labor Statistics (Occupational Outlook Handbook — Lawyers, May 2024); Major, Lindsey & Africa, 2024 In-House Counsel Compensation Survey; U.S. Department of Justice FY2024 False Claims Act recoveries (via K&L Gates summary); BarkerGilmore Healthcare & Life Sciences Compensation Survey, 2023 (via Legal Dive). Compensation figures are total cash or total compensation as reported by each survey; healthcare and life-sciences in-house seats typically sit at the upper end of cross-industry ranges, and biotech roles weight equity over cash.

04 What drives hiring

What drives legal hiring across Healthcare & Life Sciences

The demand here is counter-cyclical by design: enforcement and regulation continue regardless of the deal market, so the benches that grow are the ones that manage risk, not the ones that close transactions.

In-house, companies are deepening regulatory, compliance and privacy benches faster than general corporate legal headcount, because enforcement exposure — FCA, FDA, OCR, CMS — is the dominant risk. The CCO role is increasingly carved out as a peer to, not a report of, the CLO, partly in response to OIG guidance, creating a distinct compliance hiring track whose pay has risen fastest of any in-house legal role.

On the firm side, life-sciences and healthcare-regulatory partner additions rose across major markets in 2024–2025 amid heightened regulatory scrutiny. Lateral hiring is selective and business-case-driven, with demand especially strong for lawyers carrying FDA, DOJ, HHS-OIG and CMS government experience — government-to-firm moves have hit multi-year highs. For lawyers, the safest specializations are FDA/healthcare regulatory, fraud-and-abuse and FCA, life-sciences IP and health-data privacy — counter-cyclical skills that hold value through deal-market downturns.

05 The method

We map the regulators before we map the people.

Sector fluency is a process, not a claim. In a market where a single enforcement action can dwarf a department, the brief is written against the regulatory reality of the seat — not a boilerplate competency list.

  1. 01
    Map the exposure

    Which regulators and statutes the lawyer will face

    Before a single name is approached, we map the sub-sector's regulatory exposure — FDA, HHS-OIG, CMS, DOJ, FTC, OCR and the SEC, plus the fraud-and-abuse, FCA, HIPAA and IP regimes that actually carry the risk — and where enforcement is moving. The brief is built on that, so the hire is judged against the pressures the seat really carries.

  2. 02
    Read the market

    Where the relevant expertise is genuinely built

    We work outward from the companies, in-house teams, government bodies and practices where a lawyer would have lived the work that matters — FDA regulatory, fraud-and-abuse defense, life-sciences IP, health-data privacy, government investigations. That tells us who to approach, and who only looks the part on paper.

  3. 03
    Assess for durability

    Judgment that prevents the action, not just reacts to it

    Because the value of this team is what it prevents, we test for judgment that anticipates exposure rather than merely responding to it — and that holds across the legal and compliance tracks. The durable hire is the one who keeps a regulator, an auditor or a qui tam relator from becoming the company's problem in the first place.

The full approach — research, mapping and assessment — is set out in our methodology.

06 Adjacent markets

Related industries

Healthcare and life-sciences lawyers move along well-worn paths into and out of neighbouring sectors — digital health into technology, payers into insurance. If your mandate sits at the edge, these hubs are where it often belongs.

Or see the full map of sectors we recruit across on the industries overview.

Healthcare & Life Sciences legal recruiting, answered

What legal roles do you recruit across Healthcare & Life Sciences?

Both sides of the market, and two parallel in-house tracks. On the company side we build and strengthen legal and compliance functions — general counsel and chief legal officers, deputy and associate GCs, and the specialist leads this sector demands: FDA/regulatory counsel, fraud-and-abuse and False Claims Act counsel, health-data privacy, IP and reimbursement, plus chief compliance officers running independent, board-facing programs. See in-house counsel recruiting, compliance recruitment and legal operations. On the firm side we place partners and associates in life-sciences and healthcare-regulatory practices. The six sub-sectors below break the market down further.

How is healthcare and life-sciences legal hiring different from a general legal search?

It is built around enforcement and regulation, not deal flow. The companies that discover, make, insure and deliver care answer to overlapping federal regulators — FDA, HHS-OIG, CMS, DOJ, FTC, OCR and the SEC — and to fraud-and-abuse statutes where a single action can dwarf the cost of the team that prevents it. In FY2024, DOJ recovered $2.9B under the False Claims Act, roughly $1.7B of it from the health care industry, with a record 979 qui tam suits filed (U.S. Department of Justice). That makes legal and compliance mission-critical rather than back-office, and it means the durable hire is the specialist who understands the specific regulators and statutes of the sub-sector — not a generalist. Our methodology explains how the sector lens shapes each search.

Where is hiring demand actually growing right now?

In the regulatory-, compliance- and enforcement-driven specialties. In-house, companies are deepening regulatory, compliance and privacy benches faster than general corporate headcount, because FCA, FDA, OCR and CMS exposure is the dominant risk. The chief compliance officer role is increasingly carved out as a peer to — not a report of — the CLO, partly in response to OIG guidance, and its pay has risen fastest of any in-house legal role: roughly $693,000 in average target earnings, a 49% increase over 2022 (Major, Lindsey & Africa, 2024). On the firm side, life-sciences and healthcare-regulatory partner additions rose across major markets in 2024–2025 amid heightened regulatory scrutiny, with especially strong demand for lawyers carrying FDA, DOJ, HHS-OIG and CMS government experience.

Does the sector really pay a premium for in-house legal talent?

Consistently. Life sciences regularly tops in-house pay rankings, and the gap widens at the top of the house: a healthcare general counsel at a public company over $10B in revenue earned $1.625M in total compensation, with private peers earning roughly half in every revenue band (BarkerGilmore, 2023, via Legal Dive). Across all industries, CLO/GC average total cash compensation runs to $640,958 / $527,080 on a 2024 target basis (Major, Lindsey & Africa, 2024) — and healthcare and life-sciences seats typically sit at the upper end of that range. The premium reflects what the work prevents: the cost of a misjudged regulatory or enforcement exposure dwarfs the cost of the lawyer who anticipates it. See our salary insights to calibrate.

I'm a lawyer in healthcare or life sciences thinking about a move. Where do I start?

Confidentially. We work with senior in-house counsel and chief compliance officers, FDA/regulatory, fraud-and-abuse, privacy and life-sciences IP specialists, and law-firm partners and associates who want to move within or across the sector they know. The safest specializations — FDA/healthcare regulatory, fraud-and-abuse and FCA defense, life-sciences IP and health-data privacy — are counter-cyclical: they hold value through deal-market downturns because enforcement and regulation continue regardless. The best first step is a discreet conversation, not an application into a black box. You can submit your CV in confidence, or read our salary insights first.

My sub-sector is narrow. Can you still help?

Almost always — and the narrower the brief, the more a specialist matters, because the pool of lawyers with real, on-point experience is smaller and harder to read from a CV. We cover six healthcare and life-sciences sub-sectors, from pharmaceuticals and medical devices and diagnostics to hospitals and health systems and managed care and payers. The regulators, statutes and risk profiles differ sharply between them, so the hiring profiles do too. Open the relevant card below, or simply tell us the mandate.

Start with the sector

Tell us the mandate. We will know the regulators.

Whether you are building an in-house legal or compliance bench, underwriting a life-sciences lateral, or thinking quietly about your own next move, the conversation starts the same way — with the sub-sector and the regulators you actually operate under.